Our Pipeline
Our R&D pipeline includes several programs that address areas of significant and growing unmet medical need, such as C. diff infection, all with novel mechanism of action agents.
Clinical Studies
Clinical Study 19-0021 | C. diff Infection Treatment
A Randomized, Double-blind Evaluation of CRS3123 Versus Oral Vancomycin in Adult Patients with Clostridioides difficile Infection. Phase II is enrolling now—find a clinical site near you and contact the study coordinator to see if you may be eligible to participate!
Knowledge Portal
C. diff Infection Symptoms: An Overview
Clostridium difficile infection (CDI) is a gastrointestinal condition caused by toxin-producing strains of C. difficile bacteria. Commonly referred to as C. diff infection, this illness is...
Become a Part of Our Projects
Interested in helping further our research into novel antibacterial agents? We’d be thrilled to have your help, either as an investor, a team member, or a participant in our ongoing clinical studies.
Inquiries
Have a question or comment? Follow the link below to contact us about general inquiries.
Careers
Find work in a challenging, team-oriented environment with competitive salaries.
Clinical Studies
Learn how you can become part of our ongoing clinical study to fight deadly GI tract infections.